Application of the Alamar blue assay to determine the susceptibility to anti-tuberculosis pharmaceuticals
暂无分享,去创建一个
B. García-Pérez | J. J. Alba-Romero | E. Ruiz-Baca | J. R. Hernández | J. Luna-Herrera | M. Cervantes-Flores | A. Martínez-Romero | J. L. Ortega-Sánchez | P. Ruíz-Flores
[1] A. Palloni,et al. Older adults under a mixed regime of infectious and chronic diseases. , 2012, Salud publica de Mexico.
[2] Falk Hildebrand,et al. Origin, Spread and Demography of the Mycobacterium tuberculosis Complex , 2008, PLoS pathogens.
[3] J. Bayona,et al. Management of Extensively Drug-Resistant Tuberculosis in Peru: Cure Is Possible , 2008, PloS one.
[4] D. van Soolingen,et al. Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America. , 2008, Memorias do Instituto Oswaldo Cruz.
[5] S. Menor,et al. Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms. , 2007, Medical mycology.
[6] H. Guerra,et al. Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[7] G. Besra,et al. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice , 2007, Proceedings of the National Academy of Sciences.
[8] J. Luna-Herrera,et al. Synergistic antimycobacterial activities of sesquiterpene lactones from Laurus spp. , 2007, The Journal of antimicrobial chemotherapy.
[9] G. Drusano,et al. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. , 2007, The Journal of infectious diseases.
[10] D. van Soolingen,et al. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV- infected and non-HIV-infected patients in northern Tanzania , 2007, BMC Microbiology.
[11] Peter G. Smith,et al. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda , 2007, Annals of Clinical Microbiology and Antimicrobials.
[12] I. Khan,et al. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] J. Sifuentes-Osornio,et al. Resistencia de Mycobacterium tuberculosis en pacientes mexicanos. I. Características clínicas y factores de riesgo , 2005 .
[14] H. Langoni,et al. Isolation of Mycobacterium spp. in milk from cows suspected or positive to tuberculosis , 2001 .
[15] R. O. Castillo. Farmacorresistencia secundaria en tuberculosis. Tendencia en el Instituto Nacional de Enfermedades Respiratorias , 2001 .
[16] K. Castro,et al. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. , 2000, Archives of internal medicine.
[17] A. Rendon,et al. Dot Blot Assay for Detection of Antidiacyltrehalose Antibodies in Tuberculous Patients , 1999, Clinical Diagnostic Laboratory Immunology.
[18] G I Mejia,et al. Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] K. Moser,et al. Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. , 1998, The Western journal of medicine.
[20] Robert H. Gilman,et al. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.
[21] L. Collins,et al. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.